Entry
Name
Hepatitis B - Enhydra lutris kenyoni (northern sea otter)
Description
Hepatitis B virus (HBV) is an enveloped virus and contains a partially double-stranded relaxed circular DNA (RC-DNA) genome. After entry into hepatocytes, HBV RC-DNA is transported to the nucleus and converted into a covalently closed circular molecule cccDNA. The cccDNA is the template for transcription of all viral RNAs including the pregenomic RNA (pgRNA), encoding for 7 viral proteins: large, middle, and small envelope proteins (LHBs, MHBs, and SHBs) that form the surface antigen (HBsAg), the core antigen (HBcAg), the e antigen (HBeAg), the HBV polymerase, and the regulatory protein X (HBx). The pgRNA interacts with the viral polymerase protein to initiate the encapsidation into the core particles. Through endoplasmic reticulum, the core particles finish assembling with the envelope proteins and are released. HBV infection leads to a wide spectrum of liver diseases raging from chronic hepatitis, cirrhosis to hepatocellular carcinoma. The mechanism of liver injury is still not clear. However, HBV proteins target host proteins, involved in a variety of functions, thus regulating transcription, cellular signaling cascades, proliferation, differentiation, and apoptosis.
Class
Human Diseases; Infectious disease: viral
BRITE hierarchy
Pathway map
Ortholog table
Organism
Enhydra lutris kenyoni (northern sea otter) [GN:
elk ]
Gene
111154824 basement membrane-specific heparan sulfate proteoglycan core protein [KO:K06255 ]
111150819 tumor necrosis factor ligand superfamily member 6-like [KO:K04389 ]
111155003 LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
111154641 phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
111143470 phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
111155224 phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
111143790 phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
111142635 LOW QUALITY PROTEIN: cytochrome c, testis-specific-like [KO:K08738 ]
111141900 LOW QUALITY PROTEIN: uncharacterized protein LOC111141900 [KO:K08738 ]
111154209 nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446 ]
111141582 LOW QUALITY PROTEIN: nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332 ]
111152752 nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333 ]
111160328 nuclear factor of activated T-cells, cytoplasmic 4 isoform X1 [KO:K17334 ]
111151241 signal transducer and activator of transcription 3 isoform X1 [KO:K04692 ]
111144592 signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220 ]
111160141 signal transducer and activator of transcription 2 isoform X1 [KO:K11221 ]
111144425 voltage-dependent anion-selective channel protein 3 isoform X1 [KO:K15041 ]
111142901 cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450 ]
111147575 cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870 ]
111151973 cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X1 [KO:K09048 ]
111150050 cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048 ]
111138943 cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048 ]
111161856 cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048 ]
111152366 cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049 ]
111159049 myeloid differentiation primary response protein MyD88 [KO:K04729 ]
111153868 toll/interleukin-1 receptor domain-containing adapter protein [KO:K05403 ]
111157505 TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403 ]
111147521 TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404 ]
Compound
Reference
Authors
Caballero A, Tabernero D, Buti M, Rodriguez-Frias F
Title
Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy.
Journal
Reference
Authors
Walsh R, Locarnini S
Title
Hepatitis B precore protein: pathogenic potential and therapeutic promise.
Journal
Reference
Authors
Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS
Title
Present and future therapies of hepatitis B: From discovery to cure.
Journal
Reference
Authors
Morikawa K, Suda G, Sakamoto N
Title
Viral life cycle of hepatitis B virus: Host factors and druggable targets.
Journal
Reference
Authors
Feitelson MA, Reis HM, Tufan NL, Sun B, Pan J, Lian Z
Title
Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.
Journal
Reference
Authors
Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K
Title
Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Journal
Reference
Authors
Yoo YG, Lee MO
Title
Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.
Journal
Reference
Authors
Zhang X, Zhang H, Ye L
Title
Effects of hepatitis B virus X protein on the development of liver cancer.
Journal
Reference
Authors
Benhenda S, Cougot D, Buendia MA, Neuveut C
Title
Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis.
Journal
Reference
Authors
Benhenda S, Cougot D, Neuveut C, Buendia MA
Title
Liver cell transformation in chronic HBV infection.
Journal
Reference
Authors
Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD
Title
X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.
Journal
Reference
Authors
Park NH, Song IH, Chung YH
Title
Chronic hepatitis B in hepatocarcinogenesis.
Journal
Reference
Authors
Lin S, Zhang YJ
Title
Interference of Apoptosis by Hepatitis B Virus.
Journal
Reference
Authors
Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L
Title
Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
Journal
Reference
Authors
Kim HJ, Kim SY, Kim J, Lee H, Choi M, Kim JK, Ahn JK
Title
Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria.
Journal
Reference
Authors
Ng SA, Lee C
Title
Hepatitis B virus X gene and hepatocarcinogenesis.
Journal
Reference
Authors
Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E
Title
The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein.
Journal
Reference
Authors
Panteva M, Korkaya H, Jameel S
Title
Hepatitis viruses and the MAPK pathway: is this a survival strategy?
Journal
Reference
Authors
Lee YH, Yun Y
Title
HBx protein of hepatitis B virus activates Jak1-STAT signaling.
Journal
Reference
Authors
Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ
Title
Viral hepatocarcinogenesis: from infection to cancer.
Journal
Reference
Authors
Chami M, Oules B, Paterlini-Brechot P
Title
Cytobiological consequences of calcium-signaling alterations induced by human viral proteins.
Journal
Reference
Authors
Ganem D
Title
Virology. The X files--one step closer to closure.
Journal
Reference
Authors
Chung TW, Lee YC, Kim CH
Title
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
Journal
Reference
Authors
Gurtsevitch VE
Title
Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.
Journal
Reference
Authors
Schadler S, Hildt E
Title
HBV life cycle: entry and morphogenesis.
Journal
Reference
Authors
Ortega-Prieto AM, Dorner M
Title
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.
Journal
Reference
Authors
Nosratabadi R, Alavian SM, Zare-Bidaki M, Shahrokhi VM, Arababadi MK
Title
Innate immunity related pathogen recognition receptors and chronic hepatitis B infection.
Journal
Reference
Authors
Bagheri V, Askari A, Arababadi MK, Kennedy D
Title
Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
Journal
Reference
Authors
Zhang E, Lu M
Title
Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
Journal
Reference
Authors
Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z
Title
Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
Journal
Reference
Authors
Revill P, Yuan Z
Title
New insights into how HBV manipulates the innate immune response to establish acute and persistent infection.
Journal
Reference
Authors
Hopcraft SE, Damania B
Title
Tumour viruses and innate immunity.
Journal
Reference
Authors
Dandri M, Locarnini S
Title
New insight in the pathobiology of hepatitis B virus infection.
Journal
Related pathway
elk04620 Toll-like receptor signaling pathway
elk04622 RIG-I-like receptor signaling pathway
KO pathway
LinkDB
All DBs